Since last November, we’ve been waiting for more data from uniQure about the ongoing trial of AMT-130, expected in June. This release involves two years of data from the first, low-dose cohort of t...
At FDA meeting, gene therapy experts wrestle with fields blindspots www.biopharmadive.com/news/fda-gene-t...
quote:voda schreef op 25 maart 2021 14:15:Nederlandse start-up haalt 40 miljoen op voor corona-neusspraysGepubliceerd op 25 maart 2021 13:00 | Views: 1.761AMSTERDAM (ANP) - De Nederlandse biotechst...
Intrastriatal Administration of AAV5-miHTT in Non-Human Primates and Rats Is Well Tolerated and Results in miHTT Transgene Expression in Key Areas of Huntington Disease Pathology res.mdpi.com/d_att...
Transduction patterns in the CNS following various routes of AAV-5-mediated gene delivery. www.nature.com/articles/s41434-020-01...
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques www.nature.com/articles/s41586-020-26...Ad26 PER.C6 $JNJ ($CRXL )Janssenwww.prnewswire.com/news-releases/sing...
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques www.nature.com/articles/s41586-020-26...Ad26 PER.C6 $JNJ ($CRXL )Janssen ????????www.prnewswire.com/news-releases/sing...
GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop content.iospress.com/articles/journal...AAV2-GDNF for Advanced #ParkinsonsDisease www.clinicaltrials.gov/ct2/show/NCT01......
PF-06838435 (SPK-9001, $ONCE) Hemophilia BMean Activity 22.9 (9.89)Peak Activity29.1 (11.63)twitter.com/_b_i_o_t_e_c_h_/status/12...
Hemophilia A Gene Therapy, AMT-180, Continues to Show Activity, Safety in Animals ..................AMT-180 is a gene therapy being developed by uniQure to treat hemophilia A patients, including th...
Hoe Nederland de kennis voor een kansrijk coronavaccin uit handen gaf.Brus: “Als het aan ons had gelegen, was Nederland bij een pandemie verzekerd geweest van voldoende vaccins, maar de overheid ha...
twitter.com/_b_i_o_t_e_c_h_/status/12...
quote:dewarry schreef op 7 januari 2020 11:54:twitter.com/floszcrxl/status/12145000...Dat is snel...haha
Update (Jan.2019) on Phase I/II Clinical Trial of Intracerebral Administration of rAAV2/5hNAGLU Vector in Children with MPSIIIB www.youtube.com/watch?v=3aaKv_gcab4twitter.com/floszcrxl/status/1200...
quote:Tex Mex schreef op 3 september 2019 10:17:“Slybera”, haha.www.statnews.com/2019/09/01/biohacker...Zal wel overwaaien...Das Kopieren und Verkaufen des Arzneimittels knnte jedoch das geistige E...
Thx. Prof.!Collaboration and License Agreements with uniQure biopharma B.V.In August 2019, we entered into an Amended and Restated Collaboration and License Agreement (the Amended and Restated uniQ...
$MOR Announces Intention to Submit Marketing Authorization Application for Tafasitamab to EMA. $MOR Discloses Biomarker to Stratify Patient Population in B-MIND Study of Tafasitamab plus Bendamusti...
Gogogoooooo met die opbrengst...twitter.com/floszcrxl/status/11446148...
quote:rationeel schreef op 16 juni 2019 14:00:Nu even afwachten wat er verder gebeurt. www.bloomberg.com/amp/news/articles/2...twitter.com/floszcrxl/status/11391217...
Gene-Therapy Firm UniQure Explores Options Including SaleUniQure NV is exploring options including a potential sale amid interest from pharmaceutical companies looking to expand in gene therapy, pe...